Explainable Artificial Intelligence for Drug Discovery & Development, 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Explainable Artificial Intelligence for Drug Discovery and Development" report has been added to ResearchAndMarkets.com's offering.

This report encompasses recent advances in artificial intelligence platforms enabling drug discovery and development, while highlighting the importance of explainability in AI-driven technologies for healthcare. The report also provides an overview of the AI value chain.

Key Topics Covered

1. Recent Advances in Artificial Intelligence for Drug Discovery

  • Employing Artificial Intelligence for Drug Discovery
  • Explainable Artificial Intelligence Solutions
  • AI-based Drug Discovery Innovation Scouting
  • Explainable AI Drug Discovery: Approaches and Features

2. Clinical Trial Analysis and Key Contacts

  • Kyndi's Explainable AI Platform
  • Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/37g9kg/explainable?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery